The tumor suppressor p53 connects ribosome biogenesis to cell cycle control: A double-edged sword

Oncotarget

Volumn 1, Issue 1, 2010, Pages 43-47

  Hölzel, Michael ^a,b   Burger, Kaspar ^a   Mühl, Bastian ^a   Orban, Mathias ^a   Kellner, Markus ^a   Eick, Dirk ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; PROTEIN BOP1; PROTEIN MDM2; PROTEIN P53; PROTEIN PES1; PROTEIN WDR12; RIBOSOME PROTEIN; RNA 28S; SERINE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; BIOGENESIS; BLACKFAN DIAMOND ANEMIA; CARCINOGENESIS; CELL CYCLE REGULATION; CHROMOSOME 5Q; DNA DAMAGE; DNA SYNTHESIS; DRUG POTENCY; EMBRYO DEVELOPMENT; GENE FUNCTION; GENOTOXICITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MUTATIONAL ANALYSIS; MYELODYSPLASTIC SYNDROME; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RIBOSOME; RNA INTERFERENCE; RNA PROCESSING; RNA TRANSCRIPTION; TUMOR SUPPRESSOR GENE; ANIMAL; CELL CYCLE; CHEMISTRY; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL CYCLE; DNA DAMAGE; HUMANS; RIBOSOMAL PROTEINS; RIBOSOMES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80054840046     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.107     Document Type: Article

References (28)

1. Rubbi CP, Milner J. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. Embo J 2003;22:6068-6077.
2. Pestov DG, Strezoska Z, Lau LF. Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol Cell Biol 2001;21:4246-4255.
3. Lapik YR, Fernandes CJ, Lau LF, Pestov DG. Physical and functional interaction between Pes1 and Bop1 in mammalian ribosome biogenesis. Mol Cell 2004;15:17-29.
4. Holzel M, Rohrmoser M, Schlee M, Grimm T, Harasim T, Malamoussi A, Gruber-Eber A, Kremmer E, Hiddemann W, Bornkamm GW, Eick D. Mammalian WDR12 is a novel member of the Pes1-Bop1 complex and is required for ribosome biogenesis and cell proliferation. J Cell Biol 2005;170:367-378.
5. Grimm T, Holzel M, Rohrmoser M, Harasim T, Malamoussi A, Gruber-Eber A, Kremmer E, Eick D. Dominant-negative Pes1 mutants inhibit ribosomal RNA processing and cell proliferation via incorporation into the PeBoW-complex. Nucleic Acids Res 2006;34:3030-3043.
6. Rohrmoser M, Holzel M, Grimm T, Malamoussi A, Harasim T, Orban M, Pfisterer I, Gruber-Eber A, Kremmer E, Eick D. Interdependence of Pes1, Bop1, and WDR12 controls nucleolar localization and assembly of the PeBoW complex required for maturation of the 60S ribosomal subunit. Mol Cell Biol 2007;27:3682-3694.
7. Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L, Williams J, Lengauer C, Kinzler KW, Vogelstein B. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest 1999;104:263-269.
8. Sun XX, Dai MS, Lu H. 5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction. J Biol Chem. 2007;282:8052-8059.
9. Gilkes DM, Chen L, Chen J. MDMX regulation of p53 response to ribosomal stress. Embo J 2006;25:5614-5625.
10. Chen D, Zhang Z, Li M, Wang W, Li Y, Rayburn ER, Hill DL, Wang H, Zhang R. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene 2007;26:5029-5037.
11. Fumagalli S, Di Cara A, Neb-Gulati A, Natt F, Schwemberger S, Hall J, Babcock GF, Bernardi R, Pandolfi PP, Thomas G. Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat Cell Biol 2009;11:501-508.
12. Zhu Y, Poyurovsky MV, Li Y, Biderman L, Stahl J, Jacq X, Prives C. Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol Cell 2009;35:316-326.
13. Holzel M, Orban M, Hochstatter J, Rohrmoser M, Harasim T, Malamoussi A, Kremmer E, Langst G, Eick D. Defects in 18S or 28S rRNA processing activate the p53 pathway. J Biol Chem 2010;285:6364-6370.
14. Chakraborty A, Uechi T, Higa S, Torihara H, Kenmochi N. Loss of ribosomal protein L11 affects zebrafish embryonic development through a p53-dependent apoptotic response. PLoS One 2009;4:e4152.
15. Garcia-Cao I, Garcia-Cao M, Martin-Caballero J, Criado LM, Klatt P, Flores JM, Weill JC, Blasco MA, Serrano M. "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. Embo J 2002;21:6225- 6235.
16. Boehme KA, Blattner C. Regulation of p53--insights into a complex process. Crit Rev Biochem Mol Biol 2009;44:367- 392.
17. Blattner C. Regulation of p53: the next generation. Cell Cycle 2008;7:3149-3153.
18. Boria I, Quarello P, Avondo F, Garelli E, Aspesi A, Carando A, Campagnoli MF, Dianzani I, Ramenghi U. A new database for ribosomal protein genes which are mutated in Diamond- Blackfan Anemia. Hum Mutat 2008;29:E263-270.
19. Pellagatti A, Hellstrom-Lindberg E, Giagounidis A, Perry J, Malcovati L, Della Porta MG, Jadersten M, Killick S, Fidler C, Cazzola M, Wainscoat JS, Boultwood J. Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes. Br J Haematol 2008;142:57-64.
20. Ebert BL, Pretz J, Bosco J, Chang CY, Tamayo P, Galili N, Raza A, Root DE, Attar E, Ellis SR, Golub TR. Identifica tion of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 2008;451:335-339.
21. Czibere A, Bruns I, Junge B, Singh R, Kobbe G, Haas R, Germing. Low RPS14 expression is common in myelodysplastic syndromes without 5q- aberration and defines a subgroup of patients with prolonged survival. Haematologica 2009;94:1453-1455.
22. Austin KM, Leary RJ, Shimamura A. The Shwachman- Diamond SBDS protein localizes to the nucleolus. Blood 2005;106:1253-1258.
23. Boocock GR, Morrison JA, Popovic M, Richards N, Ellis L, Durie PR, Rommens JM. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 2003;33:97-101.
24. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A, Dokal I. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998;19:32-38.
25. Ridanpaa M, van Eenennaam H, Pelin K, Chadwick R, Johnson C, Yuan B, vanVenrooij W, Pruijn G, Salmela R, Rockas S, Makitie O, Kaitila I, de la Chapelle A. Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell 2001;104:195-203.
26. McGowan KA, Li JZ, Park CY, Beaudry, V, Tabor HK, Sabnis AJ, Zhang W, Fuchs H, de Angelis MH, Myers RM, Attardi LD, Barsh GS. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet 2008;40:963- 970.
27. Barlow JL, Drynan LF, Hewett DR, Holmes LR, Lorenzo- Abalde S, Lane AL, Jolin HE, Pannell R, Middleton AJ, Wong SH, Warren AJ, Wainscoat JS, Boultwood J, et al. A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. Nat Med 2010;16:59- 66.
28. Burger K, Mühl B, Harasim T, Rohrmoser M, Malamoussi A, Orban M, Kellner M, Gruber-Eber A, Kremmer E, Holzel M and Eick D. Chemotherapeutic drugs inhibit ribosome biogenesis at various levels. J Biol Chem 2010;285:12416-12425.